PolyModels Hub has raised £1.1 million in seed funding to ‘build the digital backbone for pharma’.
The round, led by Marathon Venture Capital, will accelerate the London startup’s mission to help pharmaceutical companies deliver breakthrough therapies faster via a software platform.
Accelerating the development of medicines is a significant societal challenge. Complex therapeutic modalities require sophisticated drug processes to obtain molecules with the desired properties while maintaining high-quality standards.
Historically, R&D expenditures per molecule have consistently increased. However, recent advancements in digital technology and data integration offer hope for reversing this trend, making the business model more sustainable.
PolyModels Hub has introduced a digital platform designed to revolutionise pharma process development. ModelFlow seamlessly integrates models, scientific data and insights into a single, cohesive product.
Prehabilitation platform founded by NHS doctors wins funding
It aims to shift the focus to advancing a company’s medicine portfolio through regulatory and business milestones by offering a robust solution for project management and the maximisation of digital tools.
“Developing a drug remains an expensive and time-consuming process. Unlike other industries, product development in pharmaceuticals relies heavily on numerous experiments with minimal knowledge transfer from past products, driven by the expertise and know-how of scientists,” said Antonio Benedetti, co-founder & CEO.
“We have witnessed first-hand the inefficiencies of traditional drug development, as well as the growing desire and business need to transform this field. Our vision for PolyModels Hub is to revolutionise how scientists, digital teams, and senior stakeholders collaborate to accelerate development efforts and bring breakthrough therapies to market faster than ever.
“With today’s advanced technology, supportive business context, and favourable regulatory framework, we believe now is the perfect time to realise this vision.”